October 4, 2007 -- WEX Pharmaceuticals, a Vancouver-based company with operations in China, will publish a post hoc analysis of a trial of its painkiller Tectin (tetrodotoxin). For WEX, the problem is that it has run out of money so that it cannot begin a trial on an endpoint that seems promising. More details...
